Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-045698
Filing Date
2024-11-06
Accepted
2024-11-06 16:08:36
Documents
76
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aadi-20240930.htm   iXBRL 10-Q 1731587
2 EX-10.2 exhibit102amendmentno03fk.htm EX-10.2 30740
3 EX-10.3 exhibit103ndesaitransition.htm EX-10.3 77374
4 EX-10.4 exhibit104litri.htm EX-10.4 81500
5 EX-31.1 aadi-20240930xex311.htm EX-31.1 10956
6 EX-31.2 aadi-20240930xex312.htm EX-31.2 10976
7 EX-32.1 aadi-20240930xex321.htm EX-32.1 5349
8 EX-32.2 aadi-20240930xex322.htm EX-32.2 5324
  Complete submission text file 0001628280-24-045698.txt   7739353

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aadi-20240930.xsd EX-101.SCH 45628
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aadi-20240930_cal.xml EX-101.CAL 59346
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aadi-20240930_def.xml EX-101.DEF 235962
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aadi-20240930_lab.xml EX-101.LAB 646739
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aadi-20240930_pre.xml EX-101.PRE 452708
79 EXTRACTED XBRL INSTANCE DOCUMENT aadi-20240930_htm.xml XML 893644
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38560 | Film No.: 241430963
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)